S100A4 and cancer: However, injection of the cancer cells directly into bone also resulted in a lower cancer mass in mtMDA-S100A4sh-injected mice than in mtMDA-Csh-injected mice (Fig. 8), suggesting that cancer-derived S100A4 modulates the bone microenvironment to support cancer cell growth.